This inventor holds 3 USPTO granted patents. Top assignees: Kyowa Hakko Kirin Co., Limited, Kyowa Hakko Kogyo Co., Ltd., Other. Active years: 2003-2009.
Location History:
- Shizuoka, JP (2003)
- Tokyo, JP (2007)
- Chiyoda-ku, JP (2009)
Company Filing History:
1 out of 272 
1 out of 730 
2 out of 834,453 Years Active: 2003-2009
Title: Hiroyuki Mio: Innovator in Sugar Chain Synthesis
Introduction
Hiroyuki Mio is a notable inventor based in Chiyoda-ku, Japan. He has made significant contributions to the field of biochemistry, particularly in the synthesis of sugar chains. With a total of 3 patents to his name, his work has implications for medical treatments and diagnostics.
Latest Patents
Hiroyuki Mio's latest patents include a transformative approach to producing sugar chains. One of his key inventions is a transformed cell harboring DNA or RNA encoding a sugar chain synthesizing agent with β1,3-N-acetylglucosaminyltransferase activity. This invention provides a novel polypeptide that is crucial for synthesizing useful sugar chains. It also includes methods for diagnosing and treating inflammatory diseases, cancer, or tumor metastasis using the polypeptide or its corresponding antibody. Another patent focuses on the process for producing sugar chains using the same β1,3-N-acetylglucosaminyltransferase, further emphasizing the potential for medical applications.
Career Highlights
Throughout his career, Hiroyuki Mio has worked with prominent companies, including Kyowa Hakko Kogyo Co., Ltd. His innovative research has positioned him as a key figure in the field of sugar chain synthesis, contributing to advancements in medical science.
Collaborations
Hiroyuki Mio has collaborated with notable colleagues such as Hisashi Narimatsu and Katsutoshi Sasaki. These partnerships have enhanced his research and expanded the impact of his inventions.
Conclusion
Hiroyuki Mio's contributions to the field of sugar chain synthesis are significant and impactful. His innovative patents pave the way for advancements in medical diagnostics and treatments. His work exemplifies the importance of research and collaboration in driving scientific progress.